References
- Jakharia N, Subramanian AK, Shapiro AE. COVID-19 in the immunocompromised host, including people with human immunodeficiency virus. Infect Dis Clin North Am 2022;36:397-421 https://doi.org/10.1016/j.idc.2022.01.006
- Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020;39:405-407 https://doi.org/10.1016/j.healun.2020.03.012
- Jeong YJ, Wi YM, Park H, Lee JE, Kim SH, Lee KS. Current and emerging knowledge in COVID-19. Radiology 2023;306:e222462
- Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, et al. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632
- Lee JE, Hwang M, Kim YH, Chung MJ, Sim BH, Chae KJ, et al. Imaging and clinical features of COVID-19 breakthrough infections: a multicenter study. Radiology 2022;303:682-692 https://doi.org/10.1148/radiol.213072
- Lee JE, Hwang M, Kim YH, Chung MJ, Sim BH, Jeong WG, et al. SARS-CoV-2 variants infection in relationship to imaging-based pneumonia and clinical outcomes. Radiology 2023;306:e221795
- Singson JRC, Kirley PD, Pham H, Rothrock G, Armistead I, Meek J, et al. Factors associated with severe outcomes among immunocompromised adults hospitalized for COVID-19 - COVID-NET, 10 states, March 2020-February 2022. MMWR Morb Mortal Wkly Rep 2022;71:878-884 https://doi.org/10.15585/mmwr.mm7127a3
- Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood 2020;136:2881-2892 https://doi.org/10.1182/blood.2020008824
- Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-Garcia A, Tseng LY, et al. SARS-CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and metaanalysis. Arthritis Rheumatol 2022;74:766-775 https://doi.org/10.1002/art.42030
- Song Q, Bates B, Shao YR, Hsu FC, Liu F, Madhira V, et al. Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the national COVID cohort collaborative. J Clin Oncol 2022;40:1414-1427 https://doi.org/10.1200/JCO.21.02419
- Ao G, Wang Y, Qi X, Nasr B, Bao M, Gao M, et al. The association between severe or death COVID-19 and solid organ transplantation: a systematic review and meta-analysis. Transplant Rev (Orlando) 2021;35:100628
- Wang Y, Feng R, Xu J, Shi L, Feng H, Yang H. An updated meta-analysis on the association between HIV infection and COVID-19 mortality. AIDS 2021;35:1875-1878 https://doi.org/10.1097/QAD.0000000000002968
- MacKenna B, Kennedy NA, Mehrkar A, Rowan A, Galloway J, Matthewman J, et al. Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform. Lancet Rheumatol 2022;4:e490-e506 https://doi.org/10.1016/S2665-9913(22)00098-4
- Yoon SH, Ham SY, Nam BD, Chae KJ, Lee D, Yoo JY, et al. Establishment of a nationwide Korean imaging cohort of coronavirus disease 2019. J Korean Med Sci 2020;35:e413
- Global Initiative on Sharing All Influenza Data (GISAID). Tracking of hCoV-19 variants [accessed on June 30, 2023]. Available at: https://gisaid.org/hcov19-variants/
- Lambrou AS, Shirk P, Steele MK, Paul P, Paden CR, Cadwell B, et al. Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants - United States, June 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:206-211 https://doi.org/10.15585/mmwr.mm7106a4
- Bertuzzi AF, Ciccarelli M, Marrari A, Gennaro N, Dipasquale A, Giordano L, et al. Impact of active cancer on COVID-19 survival: a matched-analysis on 557 consecutive patients at an Academic Hospital in Lombardy, Italy. Br J Cancer 2021;125:358-365 https://doi.org/10.1038/s41416-021-01396-9
- Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020;395:1907-1918 https://doi.org/10.1016/S0140-6736(20)31187-9
- Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020;395:1919-1926 https://doi.org/10.1016/S0140-6736(20)31173-9
- Gupta A, Desai N, Sanjeev, Chauhan P, Nityanand S, Hashim Z, et al. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India. Ann Hematol 2022;101:69-79 https://doi.org/10.1007/s00277-021-04644-3
- McInnes IB, Gravallese EM. Immune-mediated inflammatory disease therapeutics: past, present and future. Nat Rev Immunol 2021;21:680-686
- Sun J, Zheng Q, Madhira V, Olex AL, Anzalone AJ, Vinson A, et al. Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US. JAMA Intern Med 2022;182:153-162 https://doi.org/10.1001/jamainternmed.2021.7024
- Link-Gelles R, Levy ME, Natarajan K, Reese SE, Naleway AL, Grannis SJ, et al. Estimation of COVID-19 mRNA vaccine effectiveness and COVID-19 illness and severity by vaccination status during Omicron BA.4 and BA.5 sublineage periods. JAMA Netw Open 2023;6:e232598
- Au-Yong I, Higashi Y, Giannotti E, Fogarty A, Morling JR, Grainge M, et al. Chest radiograph scoring alone or combined with other risk scores for predicting outcomes in COVID-19. Radiology 2022;302:460-469 https://doi.org/10.1148/radiol.2021210986
- Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological Society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging 2020;2:e200152
- Bahremand T, Yao JA, Mill C, Piszczek J, Grant JM, Smolina K. COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada. Lancet Reg Health Am 2023;20:100461
- Mehrabi Nejad MM, Moosaie F, Dehghanbanadaki H, Haji Ghadery A, Shabani M, Tabary M, et al. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 2022;27:23
- Meshram HS, Kute V, Rane H, Dave R, Banerjee S, Mishra V, et al. Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis 2022;24:e13926
- Uaprasert N, Pitakkitnukun P, Tangcheewinsirikul N, Chiasakul T, Rojnuckarin P. Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis. Blood Cancer J 2022;12:173
- Bange EM, Han NA, Wileyto P, Kim JY, Gouma S, Robinson J, et al. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Research Square [Preprint]. 2021 [accessed on October 10, 2023]. Available at: https://doi.org/10.21203/rs.3.rs-162289/v1